Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Base editing marches on the clinic

This article has been updated

This year could see the first trials of therapies employing base editing that introduce precise single-nucleotide changes into patient genomes.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Change history

  • 07 June 2022

    In the version of this article initially published, the quote in the second paragraph in Box 2 appeared without the contextual text “addressing the similar issue of foreign Cas9 protein,” which has now been amended.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Eisenstein, M. Base editing marches on the clinic. Nat Biotechnol 40, 623–625 (2022). https://doi.org/10.1038/s41587-022-01326-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41587-022-01326-x

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing